OraSure Technologies to Acquire DNA Genotek Inc.
July 25, 2011
BETHLEHEM, Pa. - OraSure Technologies, Inc. announced today that it will acquire privately-held, DNA Genotek Inc., a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, for approximately US $53 million in cash, subject to certain adjustments. The transaction is anticipated to close in the third quarter of this [...]
July 25, 2011
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy. With heightened awareness of the impact, prevalence, cost, and severity of food allergies, ImmunoCAP [...]
TESCAN Introduces the LYRA GM: A New Multifunctional Tool for Nanotechnology
July 25, 2011
BRNO, Czech Republic - TESCAN, a world leading manufacturer of scanning electron microscopes and focused ion beam workstations has introduced the LYRA GM FIB-SEM workstation “A New Multifunctional Tool for Nanotechnology” Expanding on the success of the European FIBLYS project (https://www.fiblys.eu), this newest generation FIB-SEM workstation from TESCAN delivers state of the art integration of [...]
Oberlin College Chooses Biochrom Spectrophotometers
July 25, 2011
Oberlin College continues its emphasis on the highest level of education with its investment in top research grade spectrophotometers for its chemistry and biochemistry teaching laboratories. Oberlin chose the Biochrom WPA Biowave II UV/Visible Spectrophotometers to teach the nation’s next generation of scientists. These Biochrom spectrophotometers enable the students to engage in the most current [...]
Bio-Rad Receives FDA Premarket Application Approval for Its Fourth-Generation HIV Assay
July 25, 2011
Hercules, CA - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has received Premarket Application approval from the U.S. Food and Drug Administration for Bio-Rad's fourth-generation HIV assay, the GS HIV Combo Ag/Ab EIA (enzyme immunoassay). The GS HIV [...]
Waters CE Marks In Vitro Diagnostic MassTrak Immunosuppressants XE Kit
July 25, 2011
ATLANTA - Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®) in adult kidney and cardiac transplant patients from human whole blood samples [...]
Epic and Micro Imaging Technology Announce a Significant Equity Alliance
July 25, 2011
EPIC Corporation (the "Company"), announced that it has entered into a significant long-term equity alliance with Micro Imaging Technology, Inc. Under the terms of the signed Memorandum of Understanding, EPIC has committed to purchasing a substantial equity position in MIT and as a healthcare products and services company, it will receive the benefits of MIT's [...]
Phenomenex Case Study Documents Cost-Saving API Residual Analysis
July 25, 2011
Torrance, CA - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of a case study, written by scientists at Pfizer, that demonstrates the results of a new method for residual API (active pharmaceutical ingredient) analysis. This new solution replaces 16 older methods for [...]
July 25, 2011
ROCKVILLE, Maryland and SEOUL, Korea - Seegene today announced that Anyplex™ MTB/NTM/DR-TB Real-time Test, a total solution for diagnosing (MTB), will be introduced at the 2011 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry in Atlanta, GA, July 26-28, 2011. Every year 9.4 million people are newly infected with MTB, [...]
BioTools Inc. Enters into Cooperative Agreement with Chiral Technologies Inc.
July 22, 2011
Jupiter, Florida, USA - BioTools Inc. (BTI) announced today that it has entered into a cooperative agreement with Chiral Technologies Inc., West Chester, PA, the leader in enantioselective chromatography. The cooperative agreement will bring to our customers the most comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute [...]
